Access cutting-edge solid tumors treatment through this clinical trial at a research site in Oklahoma City. Study-provided care at no cost to qualified participants.
Access solid tumors specialists in Oklahoma City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
This is a Phase 1/2, open-label, multicenter, dose escalation and expansion study, evaluating the safety, tolerability, pharmacokinetic, preliminary anti-tumor activity, and effects on pharmacodynamic markers following administration of SLC-3010 as monotherapy and in combination with gemcitabine, in patients with various advanced solid tumors.
Sponsor: Selecxine
Check if you qualify for this solid tumors clinical trial in Oklahoma City, OK
If you're searching for solid tumors treatment options in Oklahoma City, OK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oklahoma City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.